Seeing Is Believing
Currently out of the existing stock ratings of Chalres Zhu, 405 are a BUY (77.14%), 115 are a HOLD (21.9%), 5 are a SELL (0.95%).
Analyst Chalres Zhu works at GUGGENHEIM with a stock forecast success ratio of 22.22% fulfilled within 44 days on average.
Chalres Zhu’s has documented 38 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MGNX, MacroGenics at 23-Nov-2022.
Analyst best performing recommendations are on ZYME (ZYMEWORKS . COMMON STOCK).
The best stock recommendation documented was for ZYME (ZYMEWORKS . COMMON STOCK) at 11/20/2019. The price target of $48 was fulfilled within 58 days with a profit of $9.24 (23.84%) receiving and performance score of 4.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
10
$5.96 (147.52%)
10
1 months 28 days ago
0/11 (0%)
$3.85 (62.60%)
Buy
25
$20.96 (518.81%)
30
6 months 2 days ago
2/6 (33.33%)
$19.91 (391.16%)
141
Buy
17
$12.96 (320.79%)
16
6 months 24 days ago
1/5 (20%)
$4.3 (33.86%)
6
Buy
28
$23.96 (593.07%)
43
11 months 8 days ago
0/2 (0%)
$17.42 (164.65%)
14
$9.96 (246.53%)
15
1 years 1 months 22 days ago
1/5 (20%)
$3.45 (32.70%)
147
What Year was the first public recommendation made by Chalres Zhu?